These results further support the hypothesis that IFN-γ-transfected BMSCs combined with QSFZYL may inhibit lung adenocarcinoma proliferation by suppressing the JAK2/STAT3 pathway. The gene discussed is STAT3; the disease is lung adenocarcinoma.